The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1968, 101: 141-150.
Copyright © 1968 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatten, B. A.
Right arrow Articles by Sulkin, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hatten, B. A.
Right arrow Articles by Sulkin, S. E.

Immune Response in Chiroptera to Bacteriophage øX1741

Betty A. Hatten, Rae Allen and S. Edward Sulkin

From the Department of Microbiology, The University of Texas, Southwestern Medical School, Dallas, Texas

Abstract

The immune response of bats, guinea pigs and rabbits to a series of three primary injections and a booster injection of bacteriophage {varphi}X174 was studied. Antiphage activity developed more rapidly in bats maintained at 24°C and 37°C than in other animals, but the magnitude and duration of the primary response was less, particularly in 24°C bats. Deviations in the percentage of phage inactivated by bat plasma pools from the mean indicated indirectly that individual 24°C bats varied considerably in their response to {varphi}X174. Prolonged primary production of ME-sensitive antibody was observed in 24°C bats, and 37°C bats had a large proportion of ME-sensitive antibodies throughout the first 21 days. Kinetic studies of {varphi}X174 inactivation indicated that 37°C bat antibodies developed during the latter part of the primary response did not bind phage irreversibly. Some instability was also noted in interactions between a diluted 35-day guinea pig antiserum and {varphi}X174. A booster injection of {varphi}X174 enhanced the neutralizing capacity of antibodies produced in all three animal species. Approximately 40% of the antiphage activity in 10-day postbooster plasma pools from 24°C bats was due to ME-sensitive antibody. Guinea pigs, rabbits and 37°C bats had little detectable ME-sensitive antibody during the secondary response by the assay procedures used. While the rate and extent of phage inactivation by a 30-day postbooster plasma pool from 37°C bats greatly exceeded that obtained with a comparable pool from 24°C bats, bat antibodies did not inactivate {varphi}X174 as rapidly or to the same degree as 30-day post-booster guinea pig or rabbit antisera. From these results it was concluded that the primary and secondary immune response of bats to immunization with {varphi}X174 was quantitatively and qualitatively less than the response of rabbits and guinea pigs to the same stimuli.

Footnotes

This investigation was supported in part by United States Public Health Service Research Grant AI-02316 from the Institute of Allergy and Infectious Diseases and National Science Foundation Grant GB-6612.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
R. Franka, N. Johnson, T. Muller, A. Vos, L. Neubert, C. Freuling, C. E. Rupprecht, and A. R. Fooks
Susceptibility of North American big brown bats (Eptesicus fuscus) to infection with European bat lyssavirus type 1
J. Gen. Virol., August 1, 2008; 89(8): 1998 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. L. Davis, E. C. Holmes, F. Larrous, W. H. M. Van der Poel, K. Tjornehoj, W. J. Alonso, and H. Bourhy
Phylogeography, Population Dynamics, and Molecular Evolution of European Bat Lyssaviruses
J. Virol., August 15, 2005; 79(16): 10487 - 10497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.